Memantine And Donepezil Hydrochlorides Extended-Release
Product manufactured by Amneal Pharmaceuticals Ny Llc
Indications and Purposes
| 1 Indications And Usage Memantine And Donepezil Hydrochlorides Extended-Release Capsules Are Indicated For The Treatment Of Moderate To Severe Dementia Of The Alzheimer’s Type In Patients Stabilized On 10 Mg Of Donepezil Hydrochloride Once Daily. Memantine And Donepezil Hydrochlorides Extended-Release Capsules Are A Combination Of Memantine Hydrochloride, An Nmda Receptor Antagonist, And Donepezil Hydrochloride, An Acetylcholinesterase Inhibitor, Indicated For The Treatment Of Moderate To Severe Dementia Of The Alzheimer’s Type In Patients Stabilized On 10 Mg Of Donepezil Hydrochloride Once Daily. (1) |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 2 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Donepezil Hydrochloride |
|
ZINC897251 |
| 2. Memantine Hydrochloride |
|
ZINC100003200 |